Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

Scientists believe they have discovered how the cheap painkiller aspirin can stop cancers spreading. In animal experiments they showed the drug enhanced the ability of the immune system to fight back.

Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ibuprofen and ketorolac show no significant association, a study suggests.

In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

Rise in prevalence of cardiovascular disease and rise in demand for pain management solutions are major factors that drive the growth of the global aspirin drugs market. However, availability of ...